NVNO
enVVeno Medical Corp
9.00$
-1.5%
vs. previous close
Closing price · As of: Sep 23, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 30.3% | 62.1% | 22.1% | 7.7% | 79.7% | 41.5% | 90.8% | 95.4% | 94.7% | 96.5% | 97.3% | 97.5% | |
| 3.6% | 55.1% | 3.2% | 3.5% | 77.0% | 38.1% | 88.6% | 94.9% | 10.9% | 7.4% | 3.9% | 10.4% | |
| 3.6% | 55.1% | 3.2% | 3.5% | 77.0% | 38.1% | 88.6% | 94.9% | 93.7% | 95.4% | 96.0% | 95.4% | |
| – | – | 11.2% | 1.6% | 0.9% | – | – | – | – | – | – | – | |
| – | – | 5.1% | 0.0% | – | – | – | – | – | – | – | – | |
| – | – | – | 1.1% | 0.7% | 34.1% | 8.9% | 4.5% | 1.3% | – | – | – | |
| 61.2% | 31.3% | 69.1% | 50.1% | 18.7% | – | – | – | – | – | – | – | |
| 225.9% | 161.9% | 115.9% | 369.1% | 42.8% | 71.2% | 32.6% | 5.7% | 7.0% | 5.0% | 6.2% | 8.2% | |
| 225.9% | 161.9% | 115.9% | 369.1% | 42.8% | 54.6% | 30.2% | 2.7% | 3.7% | 2.8% | 4.7% | 7.2% | |
| 66.9% | 63.7% | 35.5% | 118.2% | 0.8% | 8.4% | 5.9% | 0.5% | 0.8% | 0.7% | 0.8% | 1.3% | |
| 43.9% | 21.5% | 30.4% | 65.5% | 30.3% | 35.6% | 13.2% | 1.0% | 1.6% | 0.9% | 2.2% | 1.2% | |
| -125.9% | -61.9% | -236.7% | -502.5% | 57.2% | 28.8% | 67.4% | 94.3% | 93.0% | 95.0% | 93.8% | 91.8% | |
| -1,423.2% | -846.7% | -1,555.3% | -1,603.7% | -1,364.3% | -1,636.1% | -619.9% | -141.9% | -255.7% | -267.4% | -337.8% | -579.6% | |
| 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 2.0% |
Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.